The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines, based on unproven ...
Opinion
5hOpinion
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...
Zacks Investment Research on MSN
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Respiratory syncytial virus, or RSV, has long been the leading cause of infant hospitalization in Canada. While real-world ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
AstraZeneca Pharmaceuticals Inc. and workers who claimed they were fired for their religious objections to the company’s Covid vaccine policy agreed to end their federal discrimination lawsuit.
According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...
In 1897, amid growing resistance across the UK, angry residents took to the streets of Charlbury in a protest that turned so ...
AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback